<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-08-19</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39155542/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Age-Related Macular Degeneration and Its Genetic Risk: A Population-based Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39155542-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In a population-based setting, we confirmed higher genetic risk to be associated with more severe AMD and identified associations with high-risk features of intermediate AMD. Conjoint analyses suggested that high-risk features and late AMD might be differentially associated with genetic architecture in AMD, such as ECM remodeling. Incorporation of genetic information such as GRSs might improve AMD risk prediction &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39155847/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">TEDOVA: vaccine OSE2101 &#43;/- pembrolizumab as maintenance in platinum-sensitive recurrent ovarian cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39155847-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Ovarian cancer is a leading cause of death from gynecological cancers worldwide. Platinum-based chemotherapy provides the cornerstone of the medical management. In first line and subsequent relapses, maintenance strategies are offered to prolong intervals between lines of chemotherapy. Current maintenance options involve bevacizumab and poly ADP-ribose polymerase inhibitors, but these lines of therapy can only be used once in the disease course. Patients in first or second platinum &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39155851/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">The curious physician: exploring the role of curiosity in professionalism, patient care, and well-being</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39155851-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: This study represents the first attempt to explore physicians' perspectives on curiosity in medicine. The findings highlight the potential importance of curiosity in shaping medical professionalism and improving patient care. However, its pursuit is hampered by the challenging working conditions faced by doctors, suggesting a need for enhanced support and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39156164/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Renal and Extrarenal Phenotypes in Patients With &lt;em&gt;HNF1B&lt;/em&gt; Variants and Chromosome 17q12 Microdeletions</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39156164-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Patients with the 17q12del display a significantly better kidney survival than patients with other HNF1B variants; and for the latter, variants in the POU(s) DNA-binding domain lead to the poorest kidney survival. These are clinically relevant HNF1B kidney genotype-phenotype correlations that inform genetic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39156554/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Prevalence and Associated Factors of Cataract, Cataract Surgery and Postoperative Outcome in an Old Population in Russia: The Ural Very Old Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39156554-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Despite a relatively high prevalence of cataract surgery, this multiethnic cohort &gt;85 years of aged from Russia showed a high prevalence of cataract-related MSVI and blindness. Main causes for postoperative MSVI (prevalence: 44.6%) and blindness (prevalence: 11.7%) were AMD, glaucoma, corneal opacifications, and myopic macular degeneration. Almost all individuals aged 85+ years need cataract surgery, despite limited chance of postoperative good &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39156943/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Marginal Contribution of Pathogenic &lt;em&gt;RAD51D&lt;/em&gt; Germline Variants to Pakistani Early-Onset and Familial Breast/Ovarian Cancer Patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39156943-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: No pathogenic RAD51D variant was identified in the current study. Our study data suggested a negligible association of RAD51D variants with BC/OC risk in Pakistani &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39157442/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">A multiparametric analysis including single-cell and subcellular feature assessment reveals differential behavior of spheroid cultures on distinct ultra-low attachment plate types</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39157442-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Spheroids have become principal three-dimensional models to study cancer, developmental processes, and drug efficacy. Single-cell analysis techniques have emerged as ideal tools to gauge the complexity of cellular responses in these models. However, the single-cell quantitative assessment based on 3D-microscopic data of the subcellular distribution of fluorescence markers, such as the nuclear/cytoplasm ratio of transcription factors, has largely remained elusive. For spheroid &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39157585/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Long non-coding RNAs involved in &lt;em&gt;Drosophila&lt;/em&gt; development and regeneration</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39157585-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The discovery of functional long non-coding RNAs (lncRNAs) changed their initial concept as transcriptional noise. LncRNAs have been identified as regulators of multiple biological processes, including chromatin structure, gene expression, splicing, mRNA degradation, and translation. However, functional studies of lncRNAs are hindered by the usual lack of phenotypes upon deletion or inhibition. Here, we used Drosophila imaginal discs as a model system to identify lncRNAs involved in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39157610/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">HOVON 104, long-term follow-up of bortezomib-dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39157610-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The HOVON 104 studied bortezomib-dexamethasone induction therapy and autologous stem cell transplantation in 50 patients, of whom 35 received an autologous stem cell transplantation (ASCT). We demonstrate a 5-year overall survival (OS) of 73% and progression-free survival (PFS) of 52% for all 50 patients with a median follow-up of 61.3 months. For the 35 transplanted patients, calculated from the date of ASCT, the 5-year OS and PFS were 91% and 68%, respectively. After ASCT, the rate of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158066/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240819180915&amp;v=2.18.0.post9&#43;e462414">An unbiased lncRNAs dropout CRISPR-Cas9 screen reveals RP11-350G8.5 as a novel therapeutic target for Multiple Myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158066-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240819180915-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Multiple Myeloma (MM) is an incurable malignancy characterised by altered expression of coding and non-coding genes promoting tumour growth and drug resistance. Although the crucial role of long non-coding RNAs (lncRNAs) in MM is clearly established, the function of the non-coding RNAome, which might allow the design of novel therapeutics, is largely unknown. We performed an unbiased CRISPR-Cas9 loss-of-function screen of 671 lncRNAs in MM cells and their Bortezomib (BZB)-resistant &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158067/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240819180915&amp;v=2.18.0.post9&#43;e462414">Epigenetic Regulation of Non-canonical Menin Targets Modulates Menin Inhibitor Response in Acute Myeloid Leukemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158067-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240819180915-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Menin inhibitors that disrupt Menin-MLL interaction hold promise for treating specific acute myeloid leukemia subtypes, including KMT2A rearrangements (KMT2A-r), yet resistance remains a challenge. Here, through systematic chromatin-focused CRISPR screens, along with genetic, epigenetic, and pharmacologic studies in a variety of human and mouse KMT2A-r AML models, we uncover a potential resistance mechanism independent of canonical Menin-MLL targets. We show that a group of non-canonical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158068/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240819180915&amp;v=2.18.0.post9&#43;e462414">Deletions in the MAL gene result in loss of Mal protein, defining the rare inherited AnWj-negative blood group phenotype</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158068-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240819180915-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    The genetic background of the high prevalence red blood cell antigen AnWj has remained unresolved since its identification in 1972, despite reported associations with both CD44 and Smyd1 histone methyltransferase. Development of anti-AnWj, which may be clinically significant, is usually due to transient suppression of antigen expression, but a small number of individuals with persistent, autosomally-recessive inherited AnWj-negative phenotype have been reported. Whole exome sequencing &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158069/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240819180915&amp;v=2.18.0.post9&#43;e462414">How I approach intersectionality in hematopoietic stem cell transplantation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158069-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240819180915-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    In the context of healthcare, intersectionality refers to a framework that focuses on the ways multiple axes of social inequality intersect and compound at the macro and micro levels to produce a broad range of unequal health outcomes. With the aid of tools such as the wheel of power and privilege, this framework can help identify systemic biases hidden in plain sight in the routine diagnostic, therapeutic, and prognostic paradigms used in clinical practice. Hematopoietic stem &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158071/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240819180915&amp;v=2.18.0.post9&#43;e462414">Daratumumab in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: DELPHINUS Study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158071-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240819180915-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Patients with relapsed/refractory acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL) have poor outcomes compared with newly diagnosed, treatment-naÃ¯ve patients. The phase 2, open-label DELPHINUS study evaluated daratumumab (16 mg/kg intravenously) plus backbone chemotherapy in children with relapsed/refractory B-cell ALL (n=7) after â‰¥2 relapses and children and young adults with T-cell ALL (children, n=24; young adults, n=5) or LL (n=10) after first relapse. The primary &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158072/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240819180915&amp;v=2.18.0.post9&#43;e462414">Coagulation factor XI regulates endothelial cell permeability and barrier function in vitro and in vivo</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158072-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240819180915-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Loss of endothelial barrier function contributes to the pathophysiology of many inflammatory diseases. Coagulation factor XI (FXI) plays a regulatory role in inflammation. While activation of FXI increases vascular permeability in vivo, the mechanism by which FXI or its activated form FXIa disrupts endothelial barrier function is unknown. We investigated the role of FXIa in human umbilical vein endothelial cell (HUVEC) or human aortic endothelial cell (HAEC) permeability. The expression &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158135/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">Table Stakes for Equity - Consumer Demographic Data at a State-Based Marketplace</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158135-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158136/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">Preventing and Controlling Global Antimicrobial Resistance - Implementing a Whole-System Approach</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158136-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158139/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">Transforming Narratives of Gun Violence</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158139-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158143/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">Academic Medical Center-Public Health Partnerships for Outbreak Response - Collaborating with Underresourced Communities</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158143-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158145/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">Alpha&lt;sub&gt;1&lt;/sub&gt;-Antitrypsin Deficiency</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158145-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158146/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">An Urban Farm-Anchored Produce Prescription Program - Food as Medicine and Economic Justice</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158146-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158147/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240819180838&amp;v=2.18.0.post9&#43;e462414">A Multitiered Mentorship Model - Fostering Inclusive Pathways to Health Careers</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158147-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240819180838-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158218/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (WBMT)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158218-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Autologous hematopoietic cell transplantation (AHCT) is a commonly used treatment in multiple myeloma (MM). However, real-world global demographic and outcome data are scarce. We collected data on baseline characteristics and outcomes from 61 725 patients with newly diagnosed MM who underwent upfront AHCT between 2013 and 2017 from nine national/international registries. The primary endpoint was overall survival (OS), and the secondary endpoints were progression-free survival (PFS), &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158373/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Gold Meets Selenium: Dual Activation of Selenium-Containing Propargyl Alcohols Towards the Synthesis of 2H-Chromenes and Mechanistic Insights</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158373-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Herein, we report the synthesis of seleno-substituted chromenes from selenoalkynes and phenols. In this cascade reaction, the applied gold catalyst not only functions as a p-acid, but also as a Lewis acid, enabling the propargylic substitution in the first step to connect the oxygen carbon bond. Under the optimal reaction condition a total of 26 chromenes were accessible by this modular access. During scale up experiments, the hydrolysis of the vinylselenium substructure to the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158599/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Favorable safety profile of NOAC therapy in patients after tricuspid transcatheter edge-to-edge repair</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158599-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Results of this study indicate that NOACs may offer a favorable risk-benefit profile for patients with concomitant indication for anticoagulation therapy following &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158601/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Challenging the status quo: A scoping review of value-based care models in cardiology and electrophysiology</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158601-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: New VBHC models have the potential to improve the care process and patient experience while optimizing the costs. The implementation of this model has been insufficient mainly because it requires substantial changes in the existing infrastructures and local organization, the need to track adherence to guidelines and the evaluation of the quality of life improvement and patient satisfaction, among &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158650/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">The Use of a Comprehensive Concept of Capability for Wellbeing Assessment: A Best-Fit Framework Synthesis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158650-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Developing an instrument with the capability approach can be challenging, since the capability concept of Sen is ambiguous concerning the burdens that people experience whilst achieving their capabilities. A solution is to develop instruments with a comprehensive concept of capability, such as the concept of &lsquo;option-freedom&rsquo;. This study aims to develop a theoretical framework for instrument development with the concept of option-freedom. A best-fit framework synthesis was conducted with &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158696/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Chemigenetic Far-Red Labels and Ca&lt;sup&gt;2&#43;&lt;/sup&gt; Indicators Optimized for Photoacoustic Imaging</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158696-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Photoacoustic imaging is an emerging modality with significant promise for biomedical applications such as neuroimaging, owing to its capability to capture large fields of view deep inside complex scattering tissue. However, widespread adoption of this technique has been hindered by a lack of suitable molecular reporters for this modality. In this work, we introduce chemigenetic labels and calcium sensors specifically tailored for photoacoustic imaging, using a combination of synthetic dyes &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158736/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Erratum zu: Kardiale Biomarker vor nicht-kardiochirurgischen Eingriffen</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158736-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158743/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">VEGFD signaling balances stability and activity-dependent structural plasticity of dendrites</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158743-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Mature neurons have stable dendritic architecture, which is essential for the nervous system to operate correctly. The ability to undergo structural plasticity, required to support adaptive processes like memory formation, is still present in mature neurons. It is unclear what molecular and cellular processes control this delicate balance between dendritic structural plasticity and stabilization. Failures in the preservation of optimal dendrite structure due to atrophy or maladaptive &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158893/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Localized Nicardipine Release Implants for Prevention of Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Randomized Clinical Trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158893-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS AND RELEVANCE: These findings show that placing nicardipine release implants during microsurgical aneurysm repair can provide safe and effective prevention of moderate to severe aVS after aSAH. A phase 3 clinical trial to investigate the effect of nicardipine implants on clinical outcome may be &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39158950/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">Evaluating and Enhancing the Fitness-for-Purpose of Electronic Health Record Data: Qualitative Study on Current Practices and Pathway to an Automated Approach Within the Medical Informatics for Research and Care in University Medicine Consortium</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39158950-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The study identifies gaps between current practices in MIRACUM DICs and existing recommendations, offering insights into the complexities of assessing and reporting clinical data fitness. Additionally, a tripartite modular framework for fitness-for-purpose assessment was introduced to streamline the forthcoming implementation. It provides valuable input for developing and integrating an automated solution across multiple locations. This may include statistical comparisons &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/2103074805/Ot2SPw2i4">åˆ«åˆ€äº†åˆ«åˆ€äº†[å•èº«ç‹—]//@è‡ªé—­qwq:å½“å¹´å“ªä¼šæœ‰äººå¯¹ä»–è¯´æ²¡å…³ç³»ä½ æ‰20å²å‘¢ - è½¬å‘ @ç‚¸ä¹:&amp;ensp;è¡¥äº†04é›…å…¸å†³èµ›ï¼Œä»æ¯”èµ›ç»“æŸä¹‹ååˆ°é¢å¥–å®Œå›åå°çš„æ¥è¿‘åŠä¸ªå°æ—¶é‡Œï¼Œç‹...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-2103074805-ot2spw2i4/">
    
    
    
    
    
      
    
    åˆ«åˆ€äº†åˆ«åˆ€äº†<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@è‡ªé—­qwq<!-- raw HTML omitted -->:å½“å¹´å“ªä¼šæœ‰äººå¯¹ä»–è¯´æ²¡å…³ç³»ä½ æ‰20å²å‘¢<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@ç‚¸ä¹<!-- raw HTML omitted -->:â€‚è¡¥äº†04é›…å…¸å†³èµ›ï¼Œä»æ¯”èµ›ç»“æŸä¹‹ååˆ°é¢å¥–å®Œå›åå°çš„æ¥è¿‘åŠä¸ªå°æ—¶é‡Œï¼Œç‹ä¹å¥½åƒè¿çœ¼ç›éƒ½ä¸ä¼šçœ¨äº†ğŸ˜¢<!-- raw HTML omitted -->èµ›åå¤®è§†é‡‡è®¿ï¼Œè®°è€…è¿çº¿æŠ¥å¹•æœŸé—´ä¸€ç›´ç»´æŒP1çš„å§¿åŠ¿JPGä¸€åŠ¨ä¸åŠ¨äº†å¿«äºŒåç§’ï¼Œä¸çŸ¥é“åœ¨æƒ³äº›ä»€ä¹ˆã€‚ä¸­é—´è¢«æ’åˆ°èƒŒåŒ…æ°´æ´’å‡ºæ¥æ•´ä¸ªäººå¤±é­‚è½é­„åˆ°é¡¶ç‚¹ï¼Œæœ€åå‘Šåˆ«è®°è€…å®‰æ…°ä»–â€œç‹çš“æ²¡å…³ç³»â€ä¹Ÿä¸€ç›´å‚ç€å¤´æ‡µæ‡µçš„<!-- raw HTML omitted -->é¢å¥–çš„æ—¶å€™ï¼Œæ¡æ‰‹å¾®ç¬‘ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV16y411i7yD">ã€å¼ æ·è´¢ç»ã€‘é‡‘ä»·å†åˆ›æ–°é«˜ä¸å…¨çƒçŒ›æ–™åŠ æŒ</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv16y411i7yd/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1AW421R7ia">ã€å¼ æ·èŠä¸‰å†œä¹‹ç™¾ä¸ƒå…«ã€‘è¿›ä¸€æ­¥æé«˜åŸé•‡åŒ–ï¼Œä¸‰å†œé—®é¢˜è¦å‘å±•ä¸­è§£å†³</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1aw421r7ia/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1eS42197Ro">ã€å¼ æ·èŠç§‘æŠ€ã€‘è…¾è®¯çš„è‹¹æœç¨å®‰å“ç¨ä¸æ¶ˆè´¹è€…æƒç›Šä¹‹å·®åˆ«</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-19</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1es42197ro/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39155339/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240819181131&amp;v=2.18.0.post9&#43;e462414">PSMA-PET/CT response after metastasis-directed radiotherapy of bone oligometastases in prostate cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39155339-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240819181131-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: MDT is a very effective treatment modality for prostate cancer bone oligometastases and lesion response to MDT can be assessed using the (semi-)quantitative parameters SUV(max) and PSMA-positive lesion volume with established SUV &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OsNs8uzwF">Mulibu Farm Tiburonï¼Œåœ¨patioä¸Šå¯ä»¥çœ‹åˆ°SFã€‚åœ¨è¿™é‡Œè®©äººè§‰å¾—æ”¾æ¾ã€‚ ç¾å›½Â·Tiburon Ferry Terminal å­é™µåœ¨å¬æ­Œçš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-osns8uzwf/">
    
    
    
    
    
      
    
    Mulibu Farm Tiburonï¼Œåœ¨patioä¸Šå¯ä»¥çœ‹åˆ°SFã€‚åœ¨è¿™é‡Œè®©äººè§‰å¾—æ”¾æ¾ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç¾å›½Â·Tiburon Ferry Terminal<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default.pn">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default.pn</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OsOLBloxQ">ä¸Šå‘¨å…­NYT/Sienaå…¬å¸ƒäº†Bidené€€é€‰åæœ€é‡è¦rust beltï¼ˆé”ˆä»£ï¼‰ä¸‰å¤§æ‘†åŠ¨å·PA/MI/WIæ°‘è°ƒç»“æœï¼ˆç½‘é¡µé“¾æ¥ï¼‰ï¼ŒHarriså‡é¢†å…ˆ4%ã€‚ä»Šå¤©NYT/Sienaåˆå…¬å¸ƒäº†sun beltå››å·AZ/NC/...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-osolbloxq/">
    
    
    
    
    
      
    
    ä¸Šå‘¨å…­NYT/Sienaå…¬å¸ƒäº†Bidené€€é€‰åæœ€é‡è¦rust beltï¼ˆé”ˆä»£ï¼‰ä¸‰å¤§æ‘†åŠ¨å·PA/MI/WIæ°‘è°ƒç»“æœï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç½‘é¡µé“¾æ¥<!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼‰ï¼ŒHarriså‡é¢†å…ˆ4%ã€‚ä»Šå¤©NYT/Sienaåˆå…¬å¸ƒäº†sun beltå››å·AZ/NC/NV/GAçš„æ°‘è°ƒç»“æœï¼ŒHarrisåœ¨AZé¢†å…ˆ5%ï¼Œåœ¨éæ‘†åŠ¨å·NCé¢†å…ˆ2%ï¼›åœ¨NVè½å1%ï¼Œåœ¨GAè½å5%ã€‚è¿™ä¸ªæ°‘è°ƒæ˜¾ç¤ºæœ¬æ¥Bidenè¿™å››ä¸ªå°‘æ•°æ—è£”ï¼ˆéè£”å’Œæ‹‰ä¸è£”ï¼‰å å¤§æ¯”é‡çš„å·å‡è½åï¼›ä½† &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OsPt6na8y">æˆ‘çš„å¿ƒç†åŒ»ç”Ÿï¼ˆtherapistï¼‰åœ¨æ¯æ¬¡å¿ƒç†å’¨è¯¢ï¼ˆsessionï¼‰åéƒ½ä¼šç»™æˆ‘å‘ä¸€ä¸ªæ•™å­¦åŠ¨ç”»ã€‚æˆ‘è¿™å‘¨æ”¶åˆ°çš„ä¸¤ä¸ªæ•™å­¦è§†é¢‘æ˜¯ä»·å€¼ï¼ˆvalueï¼‰å’Œä¿¡å¿µï¼ˆmindfulnessï¼‰ã€‚æŠŠä¸¤ä¸ªè§†é¢‘çš„...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-ospt6na8y/">
    
    
    
    
    
      
    
    æˆ‘çš„å¿ƒç†åŒ»ç”Ÿï¼ˆtherapistï¼‰åœ¨æ¯æ¬¡å¿ƒç†å’¨è¯¢ï¼ˆsessionï¼‰åéƒ½ä¼šç»™æˆ‘å‘ä¸€ä¸ªæ•™å­¦åŠ¨ç”»ã€‚æˆ‘è¿™å‘¨æ”¶åˆ°çš„ä¸¤ä¸ªæ•™å­¦è§†é¢‘æ˜¯ä»·å€¼ï¼ˆvalueï¼‰å’Œä¿¡å¿µï¼ˆmindfulnessï¼‰ã€‚æŠŠä¸¤ä¸ªè§†é¢‘çš„è¦ä¹‰ç®€å•æ€»ç»“ä¸€ä¸‹å°±æ˜¯ä¸¤ç‚¹ï¼šä¸è¦ä¸åˆ«äººæ¯”è¾ƒï¼›ä¸è¦å› ä¸ºä»–äººåˆ¶å®šçš„æ ‡å‡†è€Œç„¦è™‘ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->ä¸è¦ä¸äººæ¯”å…¶å®è¯´èµ·æ¥ç®€å•ï¼Œä½†åšèµ·æ¥å¾ˆéš¾ã€‚å¾ˆå¤šäººå°æ—¶å€™ç»å¸¸è¢«å®¶é•¿æˆ–è€å¸ˆæ‹¿æ¥ä¸åˆ«çš„å­©å­æ¯”è¾ƒï¼›åŒæ ·æ˜¯å°æ—¶å€™ï¼Œå½“åˆ«äººæœ‰åŒå´­æ–°çš„è€å…‹çƒé‹æ—¶ï¼Œæˆ‘ä»¬è‡ªå·±ä¹Ÿä¼šæƒ³å»æ‹¥æœ‰ä¸€åŒï¼Œå‡ºå‘ç‚¹æ˜¯ä¸ºäº†å¯»æ‰¾å¿ƒç†å¹³è¡¡ã€‚æˆå¹´åï¼Œè¿™ç§æ¯”è¾ƒæ›´æ˜¯æ— å¤„ä¸åœ¨ï¼Œå…¸å‹çš„å¦‚æˆ¿å­ã€è½¦ã€å·¥èµ„ã€å­å¥³æ•™è‚²ç­‰ç­‰ã€‚è¿™ç§æ¯”è¾ƒå·²ç»æˆä¸ºäº†å¾ˆå¤šäººçš„æ€ç»´å®šåŠ¿ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->æœ‰è¶£çš„æ˜¯ï¼Œæˆ‘åœ¨å›½å†…æ—¶è®¤è¯†ä¸å°‘æ¸…åæœ¬ç§‘ç”Ÿï¼Œæˆ‘è§‰å¾—ä»–ä»¬å·²ç»æ˜¯ä¸‡é‡ŒæŒ‘ä¸€çš„çš„å¤©ä¹‹ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OsTPc7xPr">ğŸ”»å¦å¤–ï¼Œä»Šå¤©æœ‰å¾ˆå¤šè´¦å·ä¸€ç›´åœ¨åˆ·â€œæ²¡æœ‰è¿‡ä¸­çº¿â€ã€â€œæ‰¿è®¤ä¸­çº¿â€ã€‚ğŸ”»é€šè¿‡å…¬å¼€çš„AISä¿¡æ¯æŸ¥è¯¢äº†ä¸€ä¸‹å·¡èˆªè½¨è¿¹å¦‚å›¾ï¼Œåœ¨æµ·å³¡å†…å·¡èˆªéƒ½åœ¨æ‰€è°“çš„â€œä¸­çº¿â€ä¸œä¾§ï¼ˆé å°æ¹¾...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ostpc7xpr/">
    
    
    
    
    
      
    
    ğŸ”»å¦å¤–ï¼Œä»Šå¤©æœ‰å¾ˆå¤šè´¦å·ä¸€ç›´åœ¨åˆ·â€œæ²¡æœ‰è¿‡ä¸­çº¿â€ã€â€œæ‰¿è®¤ä¸­çº¿â€ã€‚<!-- raw HTML omitted -->ğŸ”»é€šè¿‡å…¬å¼€çš„AISä¿¡æ¯æŸ¥è¯¢äº†ä¸€ä¸‹å·¡èˆªè½¨è¿¹å¦‚å›¾ï¼Œåœ¨æµ·å³¡å†…å·¡èˆªéƒ½åœ¨æ‰€è°“çš„â€œä¸­çº¿â€ä¸œä¾§ï¼ˆé å°æ¹¾å²›ä¸€ä¾§ï¼‰ï¼Œè·ç¦»æ‰€è°“â€œä¸­çº¿â€æœ€è¿‘è·ç¦»çº¦2æµ·é‡Œï¼Œæœ€è¿œè¾¾åˆ°äº†çº¦22æµ·é‡Œã€‚<!-- raw HTML omitted -->ğŸ”»è¿™å°±ç›¸å½“äºæ‰§æ³•å·¡èˆªæ—¶å‹æ ¹ä¸æ‰¿è®¤æ‰€è°“â€œä¸­çº¿â€å­˜åœ¨äº†ã€‚<!-- raw HTML omitted -->ğŸ”»è­¦æƒ•æœ‰äº›æµ‘æ°´æ‘¸é±¼ã€æ··æ·†è§†å¬çš„ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OsTTR70Jj">ğŸ”»ä¸ºæ¯›æˆ‘çš„é¢„è½½å¡ä½äº†ï¼Ÿ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-osttr70jj/">
    
    
    
    
    
      
    
    ğŸ”»ä¸ºæ¯›æˆ‘çš„é¢„è½½å¡ä½äº†ï¼Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OsTU4aqta">å·¡èˆªè·¯çº¿æ˜¯æ ¹æ®èˆªè¡Œé€Ÿåº¦ç€è‰²çš„ã€‚//@ç‰å…°é”ˆå¸•:å›å¤@ä¸¸å­åŒ—æç†Š:æ„Ÿè°¢èµæ•™[ä½œæ–]ã€‚é‚£æ ¹æµ…è“çº¿æ€ä¹ˆæœ‰ä¸€å°æ®µå‘ˆç°ç»¿è‰²ï¼Œè¿™åº”è¯¥æ²¡ä»€ä¹ˆåˆ«çš„æ„æ€è¡¨è¾¾å§ï¼Ÿ //@ç‰å…°é”ˆå¸•:æ²¡...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ostu4aqta/">
    
    
    
    
    
      
    
    å·¡èˆªè·¯çº¿æ˜¯æ ¹æ®èˆªè¡Œé€Ÿåº¦ç€è‰²çš„ã€‚//<!-- raw HTML omitted -->@ç‰å…°é”ˆå¸•<!-- raw HTML omitted -->:å›å¤<!-- raw HTML omitted -->@ä¸¸å­åŒ—æç†Š<!-- raw HTML omitted -->:æ„Ÿè°¢èµæ•™<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ã€‚é‚£æ ¹æµ…è“çº¿æ€ä¹ˆæœ‰ä¸€å°æ®µå‘ˆç°ç»¿è‰²ï¼Œè¿™åº”è¯¥æ²¡ä»€ä¹ˆåˆ«çš„æ„æ€è¡¨è¾¾å§ï¼Ÿ //&lt;a href=&ldquo;<a href="https://weibo.com/n/%E7%8E%89%E5%85%B0%E9%94%88%E5%B8%25">https://weibo.com/n/%E7%8E%89%E5%85%B0%E9%94%88%E5%B8%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OsTWr9KdR">ğŸ”»ä½ çŒœï¼ŸğŸ”»æ— è®ºå¦‚ä½•ï¼Œè®¨è®ºä¸€ä¸ªâ€œä¸å­˜åœ¨â€çš„ä¸œè¥¿å¹¶æ²¡æœ‰ä»€ä¹ˆæ„ä¹‰ï¼Œä½†æ˜¯æˆ‘ä»¬è¿™è¾¹çš„è®¸å¤šç½‘å‹å´åˆè¦ä¸€éåˆä¸€éçš„æ‹¿å‡ºæ¥é—®ï¼Œä¸å¾—ä¸ä¸€éåˆä¸€éçš„è§£é‡Šã€‚ğŸ”»å¯¹æœ‰äº›äºº...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ostwr9kdr/">
    
    
    
    
    
      
    
    ğŸ”»ä½ çŒœï¼Ÿ<!-- raw HTML omitted -->ğŸ”»æ— è®ºå¦‚ä½•ï¼Œè®¨è®ºä¸€ä¸ªâ€œä¸å­˜åœ¨â€çš„ä¸œè¥¿å¹¶æ²¡æœ‰ä»€ä¹ˆæ„ä¹‰ï¼Œä½†æ˜¯æˆ‘ä»¬è¿™è¾¹çš„è®¸å¤šç½‘å‹å´åˆè¦ä¸€éåˆä¸€éçš„æ‹¿å‡ºæ¥é—®ï¼Œä¸å¾—ä¸ä¸€éåˆä¸€éçš„è§£é‡Šã€‚<!-- raw HTML omitted -->ğŸ”»å¯¹æœ‰äº›äººæ¥è¯´ï¼Œç ´â€œæµ·å³¡ä¸­çº¿â€æ˜“ï¼Œç ´â€œå¿ƒä¸­ä¸­çº¿â€éš¾ã€‚<!-- raw HTML omitted -->ğŸ”»AISæ•°æ®æ¥è‡ªVF <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OsTZLpWXv">ğŸ”»è€çº ç»“â€œæ¸”èˆ¹è¿‡æ²¡è¿‡æµ·å³¡ä¸­çº¿â€å…¶å®å¾ˆæ— èŠï¼Œéšä¾¿ç‚¹å‡ æ¡ä½œä¸šä¸­çš„ä¸­å›½æ¸”èˆ¹ï¼Œçœ‹çœ‹ä»–ä»¬åœ¨å“ªã€‚ğŸ”»AISæ•°æ®æ¥è‡ªVF [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ostzlpwxv/">
    
    
    
    
    
      
    
    ğŸ”»è€çº ç»“â€œæ¸”èˆ¹è¿‡æ²¡è¿‡æµ·å³¡ä¸­çº¿â€å…¶å®å¾ˆæ— èŠï¼Œéšä¾¿ç‚¹å‡ æ¡ä½œä¸šä¸­çš„ä¸­å›½æ¸”èˆ¹ï¼Œçœ‹çœ‹ä»–ä»¬åœ¨å“ªã€‚<!-- raw HTML omitted -->ğŸ”»AISæ•°æ®æ¥è‡ªVF <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;b &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OsU4m8tfB">ğŸ”»è¿™äº›åœ¨èº«ä½“æ§åˆ¶ã€æ—¶é—´æŒæ¡å’Œæ¿€çƒˆå¯¹æŠ—ä¸­åšåˆ°é¡¶çº§çš„ä¸€æµè¿åŠ¨å‘˜ï¼Œåªè¦æ€§æ ¼æ²¡ç¼ºé™·ï¼Œæ— è®ºäººç”Ÿé“è·¯å¦‚ä½•ç»§ç»­ï¼Œéƒ½æ˜¯è¶…è¶Šå¸¸äººçš„å­˜åœ¨ã€‚ğŸ”»æœ‰äº›äººè‡ªå·±çš„èŒä¸šç”Ÿæ¶¯ã€æœ¬èŒ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-osu4m8tfb/">
    
    
    
    
    
      
    
    ğŸ”»è¿™äº›åœ¨èº«ä½“æ§åˆ¶ã€æ—¶é—´æŒæ¡å’Œæ¿€çƒˆå¯¹æŠ—ä¸­åšåˆ°é¡¶çº§çš„ä¸€æµè¿åŠ¨å‘˜ï¼Œåªè¦æ€§æ ¼æ²¡ç¼ºé™·ï¼Œæ— è®ºäººç”Ÿé“è·¯å¦‚ä½•ç»§ç»­ï¼Œéƒ½æ˜¯è¶…è¶Šå¸¸äººçš„å­˜åœ¨ã€‚<!-- raw HTML omitted -->ğŸ”»æœ‰äº›äººè‡ªå·±çš„èŒä¸šç”Ÿæ¶¯ã€æœ¬èŒå·¥ä½œåšçš„éƒ½å¾ˆå¹³åº¸ï¼Œå´å¤§è¨€ä¸æƒ­â€œè®©æˆ‘æ¥æ‰¹è¯„æ‰¹è¯„ä½ â€<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å…¨çº¢å©µè·³207Cç»å¸¸å¹³æ‘”è¿›æ°´é‡Œ#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/639b1bfbly1hssimleqltj21em0r1e2l.jpg%22">https://tvax2.sinaimg.cn/large/639b1bfbly1hssimleqltj21em0r1e2l.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OsUaa5gxT">â€œæ¶æ€§â€ä¸¤å­—æ²¡å˜ï¼Œåƒå°ğŸ¸æ´—è„‘åŒ…è¿˜åˆ°å¤„æ§ç€ç»™äººçœ‹æ˜¯å¾ˆæç¬‘çš„ã€‚ æŸ¥çœ‹å›¾ç‰‡ //@å²šé£å±±:è¿‡ä¸­çº¿å¦‚ä½•ï¼Œä¸è¿‡ä¸­çº¿åˆå¦‚ä½•ï¼Ÿ214æ¶æ„æ’èˆ¹äº‹ä»¶å˜æˆ214æ’èˆ¹äº‹ä»¶åå›½äººä¸€åˆ‡è¯•...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-osuaa5gxt/">
    
    
    
    
    
      
    
    â€œæ¶æ€§â€ä¸¤å­—æ²¡å˜ï¼Œåƒå°ğŸ¸æ´—è„‘åŒ…è¿˜åˆ°å¤„æ§ç€ç»™äººçœ‹æ˜¯å¾ˆæç¬‘çš„ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¥çœ‹å›¾ç‰‡<!-- raw HTML omitted --><!-- raw HTML omitted --> //<!-- raw HTML omitted -->@å²šé£å±±<!-- raw HTML omitted -->:è¿‡ä¸­çº¿å¦‚ä½•ï¼Œä¸è¿‡ä¸­çº¿åˆå¦‚ä½•ï¼Ÿ214æ¶æ„æ’èˆ¹äº‹ä»¶å˜æˆ214æ’èˆ¹äº‹ä»¶åå›½äººä¸€åˆ‡è¯•å›¾åœ¨æµ·ä¸Šæ‰¾è¡¥çš„åšæ³•éƒ½å¾ˆå¯ç¬‘<!-- raw HTML omitted -->&lt;img alt=&quot;[æŒ–é¼»]&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OsUeMFwJ0">ğŸ”»å† å†›ï¼Œå¥½éš¾ã€‚#æ¨ŠæŒ¯ä¸œå›åº”é€€å½¹ä¼ é—»# [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-osuemfwj0/">
    
    
    
    
    
      
    
    ğŸ”»å† å†›ï¼Œå¥½éš¾ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#æ¨ŠæŒ¯ä¸œå›åº”é€€å½¹ä¼ é—»#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OsUgn1jQ9">å°±æ­£å¸¸å‡ åå¸§çš„é…ç½®//@å¶Vinde:æƒ³é—®é—®åŒ…å§ç”µè„‘å•¥é…ç½® - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»ä¸ºæ¯›æˆ‘çš„é¢„è½½å¡ä½äº†ï¼Ÿ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-osugn1jq9/">
    
    
    
    
    
      
    
    å°±æ­£å¸¸å‡ åå¸§çš„é…ç½®//<!-- raw HTML omitted -->@å¶Vinde<!-- raw HTML omitted -->:æƒ³é—®é—®åŒ…å§ç”µè„‘å•¥é…ç½®<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»ä¸ºæ¯›æˆ‘çš„é¢„è½½å¡ä½äº†ï¼Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OsUQntRVb">ğŸ”»åˆšåˆšã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-osuqntrvb/">
    
    
    
    
    
      
    
    ğŸ”»åˆšåˆšã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OsO1Mm00P">æ—©é¤æ–°å“ç§ï¼šé¹Œé¹‘è›‹ã€‚å–µå¥¶å¥¶è¯´å¬è¯´é¹Œé¹‘è›‹çš„è›‹ç™½è´¨å«é‡æ˜¯é¸¡è›‹çš„3å€ï¼Œæˆ‘é—®å¬è°è¯´ï¼Ÿå¥¹è¯´ç½‘ä¸Šè¯´çš„ã€‚æˆ‘è¯´è‚¯å®šæ˜¯é¹Œé¹‘è‡ªå·±åœ¨ç½‘ä¸Šè¯´çš„ï¼Œå¥¹è¯´ç®¡ä»–è°è¯´çš„ï¼Œåæ­£æˆ‘æƒ³åƒé¹Œé¹‘...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-oso1mm00p/">
    
    
    
    
    
      
    
    æ—©é¤æ–°å“ç§ï¼šé¹Œé¹‘è›‹ã€‚å–µå¥¶å¥¶è¯´å¬è¯´é¹Œé¹‘è›‹çš„è›‹ç™½è´¨å«é‡æ˜¯é¸¡è›‹çš„3å€ï¼Œæˆ‘é—®å¬è°è¯´ï¼Ÿå¥¹è¯´ç½‘ä¸Šè¯´çš„ã€‚æˆ‘è¯´è‚¯å®šæ˜¯é¹Œé¹‘è‡ªå·±åœ¨ç½‘ä¸Šè¯´çš„ï¼Œå¥¹è¯´ç®¡ä»–è°è¯´çš„ï¼Œåæ­£æˆ‘æƒ³åƒé¹Œé¹‘è›‹ã€‚é©¬ä¸Šåœ¨ç›’é©¬ä¸‹å•ï¼Œä¹°äº†ä¸€ç›’0æŠ—ç”Ÿç´ çš„é¹Œé¹‘è›‹ã€‚ä¸è¯´è›‹ç™½è´¨å«é‡ï¼Œå£æ„Ÿç¡®å®æ¯”é¸¡è›‹å¥½3å€ã€‚<!-- raw HTML omitted --> æˆ‘å¾—ä»‹ç»ä¸€ä¸‹è”¬èœè‰²æ‹‰ï¼Œä½œæ–™ä¸‰ï¼šé£Ÿç›ã€é»‘èƒ¡æ¤’ç²‰å’Œæ©„æ¦„æ²¹ã€‚é‡ç‚¹æ˜¯èƒ¡æ¤’ç²‰ã€‚è¿™ä¸ªèƒ¡æ¤’ç²‰æ˜¯æˆ‘ä»¬åœ¨åœŸè€³å…¶è¶…å¸‚ä¹°çš„ï¼Œå›å›½æ—¶æˆ‘è¯´æ‰”äº†ï¼Œè¢«å–µå¥¶å¥¶æ‚„æ‚„å¸¦å›æ¥ã€‚æ¯”è¾ƒæˆéƒ½è¶…å¸‚çš„èƒ¡æ¤’ç²‰ï¼Œå·®åˆ«çœŸçš„å¾ˆå¤§ã€‚å¦‚æœæˆ‘è¯´åœŸè€³å…¶èƒ¡æ¤’ç²‰æ¯”ä¸­å›½èƒ¡æ¤’ç²‰é¦™ï¼Œä¸ä¼šè¢«è®¤ä¸ºæ˜¯å´‡æ´‹åªšå¤–å§ï¼Ÿç°åœ¨æœ‰ç‚¹åæ‚”ï¼Œåº”è¯¥å¤šä¹°ä¸¤è¢‹ã€‚æˆ‘åœ¨äº¬ä¸œã€ç›’é©¬æœç´¢ï¼Œéƒ½æ²¡æœ‰åœŸè€³å…¶èƒ¡æ¤’ç²‰ã€‚å–µå¥¶å¥¶è¯´çœ‹çœ‹æœ€è¿‘æœ‰æ²¡æœ‰æœ‹å‹åˆ°åœŸè€³å…¶æ—…æ¸¸ï¼Œè®©å¸®å¿™ä¹°ä¸¤è¢‹ï¼Ÿæˆ‘è¯´é™¤éäººå®¶è‡ªç”±è¡Œï¼Œå¦‚æœè·Ÿå›¢æ¸¸ï¼Œå’‹å¯èƒ½å»é€›ç”Ÿæ´»è¶…å¸‚ï¼Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3515092710/OsPx0APOg">ä¹¦ä¸Šè¯´ï¼Œæ¯å‘¨åº”è¯¥åƒä¸¤æ¬¡é±¼å’Œè±†è…ã€‚å–µå¥¶å¥¶å°±åœ¨ç›’é©¬é²œç”Ÿä¸‹å•ï¼Œä¹°äº†ä¸€ç›’é²ˆé±¼ç‰‡å’Œè±†è…ï¼Œè¦æˆ‘åšè±†è…é±¼ã€‚æˆ‘è¯´è¿™ç§é±¼ç‰‡æ˜¯æ‹¿æ¥çƒ«ç«é”…çš„ï¼Œå¥¹è¯´æœªå¿…çƒ«ç«é”…çš„å°±ä¸èƒ½åšæˆè±†è…...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3515092710-ospx0apog/">
    
    
    
    
    
      
    
    ä¹¦ä¸Šè¯´ï¼Œæ¯å‘¨åº”è¯¥åƒä¸¤æ¬¡é±¼å’Œè±†è…ã€‚å–µå¥¶å¥¶å°±åœ¨ç›’é©¬é²œç”Ÿä¸‹å•ï¼Œä¹°äº†ä¸€ç›’é²ˆé±¼ç‰‡å’Œè±†è…ï¼Œè¦æˆ‘åšè±†è…é±¼ã€‚æˆ‘è¯´è¿™ç§é±¼ç‰‡æ˜¯æ‹¿æ¥çƒ«ç«é”…çš„ï¼Œå¥¹è¯´æœªå¿…çƒ«ç«é”…çš„å°±ä¸èƒ½åšæˆè±†è…é±¼ï¼Ÿæˆ‘è¯´ä½ æ‡‚ä¸ªå±ï¼Œåªæ™“å¾—åƒåƒåƒï¼é¡»çŸ¥åšè±†è…é±¼çš„é±¼å¿…é¡»åˆ‡æˆå—ï¼Œè€Œä¸æ˜¯åˆ‡ç‰‡ã€‚å¥¹è¯´é‚£å°±æŠŠé±¼ç‰‡åšæˆé…¸èœé±¼ï¼Œè±†è…åšæˆéº»å©†è±†è…ï¼Ÿæˆ‘è¯´ä½ è¯´å¾—è½»å·§ï¼Œåƒæ ¹ç¯è‰â€”â€”èŠ±æ¤’ç²‰éƒ½æ²¡æœ‰ï¼Œå’‹ä¸ªåšéº»å©†è±†è…å‘¢ï¼Ÿå¥¹è¯´èŠ±æ¤’ç²‰å¤šç®€å•å˜›ï¼ŒæŠ“ä¸€æŠŠèŠ±æ¤’åœ¨é”…é‡Œç‚’é¦™ï¼Œå†·å´åï¼Œç”¨èˆ‚é’µæŠŠèŠ±æ¤’èˆ‚æˆç²‰ï¼Œä¸å°±æ˜¯èŠ±æ¤’ç²‰ï¼ŸèŠ±æ¤’ç²‰å¾ˆå¿«å°±åˆ¶é€ å‡ºæ¥äº†ï¼Œéº»å©†è±†è…é¡ºåˆ©è¯ç”Ÿï¼Œæˆ‘è¯´æ¯”ä½•æ°éª¨ç§‘åŒ»é™¢é£Ÿå ‚çš„éº»å©†è±†è…å¥½åƒå§ï¼Ÿå–µå¥¶å¥¶è¯´é€—æ˜¯ã€‚é±¼æ²¡æœ‰åšæˆé…¸èœé±¼â€”â€”æˆ‘è®¤ä¸ºç”¨è¶…å¸‚å–çš„é…¸èœé±¼è°ƒæ–™åŒ…æ¥çƒ¹é±¼ï¼Œç­‰äºé¢„åˆ¶èœï¼Œæ²¡æœ‰åˆ›é€ æ€§ã€‚æˆ‘æ˜¯ç”¨é²œèŠ±æ¤’å’Œå§œè‘±è’œï¼ŒæŠŠé²ˆé±¼ç‰‡åšæˆäº†å¯èƒ½åªæœ‰å››å·äººé‡åº†äººæ‰æ•¢åƒçš„æ¤’éº»é±¼ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sin">https://tvax3.sin</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OsPBLzlg2">å¤ºå°‘ï¼Ÿ - è½¬å‘ @Aniplex:&amp;ensp;ã€ANIPLEXè½¬ç°é€šçŸ¥ã€‘ä¹ƒæœ¨å‚46 é›†æ¢å¼å¡ç‰Œå¡å«å·²ç»ç°è´§ä¸Šæ¶å•¦ï¼æ”¶çº³ç›’å”®ä»·ï¼š70å…ƒå¡å«(3æœŸç”Ÿ/4æœŸç”Ÿ/5æœŸç”Ÿ)å”®ä»·ï¼šå„190å…ƒ åº—é“ºï¼šğŸ‘...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ospblzlg2/">
    
    
    
    
    
      
    
    å¤ºå°‘ï¼Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@Aniplex<!-- raw HTML omitted -->:â€‚ã€ANIPLEXè½¬ç°é€šçŸ¥ã€‘<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ƒæœ¨å‚46<!-- raw HTML omitted --><!-- raw HTML omitted --> é›†æ¢å¼å¡ç‰Œå¡å«å·²ç»ç°è´§ä¸Šæ¶å•¦ï¼<!-- raw HTML omitted -->æ”¶çº³ç›’å”®ä»·ï¼š70å…ƒ<!-- raw HTML omitted -->å¡å«(3æœŸç”Ÿ/4æœŸç”Ÿ/5æœŸç”Ÿ)å”®ä»·ï¼šå„190å…ƒ <!-- raw HTML omitted -->åº—é“ºï¼šğŸ‘aniplexæ——èˆ°åº— &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OsPj09Y6J">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.ç·’è¡Œè¨˜fb [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-ospj09y6j/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.ç·’è¡Œè¨˜fb &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1hsrvjosprij30u00k0mzp.jpg%22">https://tvax3.sinaimg.cn/large/006z6nxLgy1hsrvjosprij30u00k0mzp.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OsQx03Sla">//@é¡¶ç­†TENä½¿:ä¹…ä¿å²ç»ªé‡Œ[è€¶][äº²äº²] - è½¬å‘ @é•·äº­æ¢…:&amp;ensp;æ¢…æ³½ç¾æ³¢#æ¢…æ³½ç¾æ³¢# 2024.08.12 æ‰‹æœºmailã€Œæ¢…ç»ªã€&lt;å›¾&gt;æ˜¯æ¢…ç»ªå“¦â˜ºï¸â˜ºï¸MVä¸€ç›´åœ¨ä¸€èµ· [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-osqx03sla/">
    
    
    
    
    
      
    
    //<!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[è€¶]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/others/h_ye-8d6db3a711.png%22">https://h5.sinaimg.cn/m/emoticon/icon/others/h_ye-8d6db3a711.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OsRlO1JCP">å¥½æƒ³è§é‡åº†å¥³äºº [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-osrlo1jcp/">
    
    
    
    
    
      
    
    å¥½æƒ³è§é‡åº†å¥³äºº <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/OsVj3jCuV">æ¯å¤©æ™šä¸Šéƒ½æœ‰ä¸ç¡è§‰çš„ç†ç”±æ˜¨æ™šæ˜¯å’ŒèšŠå­å¤§æˆ˜åˆ°äº”ç‚¹ä»Šå¤©æ˜¯é™ªä¼´åˆ°ä¸‰ç‚¹åˆæ‰“æ¸¸æˆåˆ°å››ç‚¹å¤šå”‰è¿™æ—¥å­è¿‡å¾—ï¼Œä»Šæ™šä¸€å®šæ—©ç¡ğŸš¬</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-osvj3jcuv/">
    
    
    
    
    
      
    
    æ¯å¤©æ™šä¸Šéƒ½æœ‰ä¸ç¡è§‰çš„ç†ç”±<!-- raw HTML omitted -->æ˜¨æ™šæ˜¯å’ŒèšŠå­å¤§æˆ˜åˆ°äº”ç‚¹<!-- raw HTML omitted -->ä»Šå¤©æ˜¯é™ªä¼´åˆ°ä¸‰ç‚¹åˆæ‰“æ¸¸æˆåˆ°å››ç‚¹å¤š<!-- raw HTML omitted -->å”‰è¿™æ—¥å­è¿‡å¾—ï¼Œä»Šæ™šä¸€å®šæ—©ç¡ğŸš¬  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OsRBt22yQ">ä¸æ„§æ˜¯æˆ‘ä»¬å±±è¥¿é˜Ÿåå®¿æ£‹æ‰‹æˆ˜é¹° - è½¬å‘ @æ£‹æ‰‹æˆ˜é¹°:&amp;ensp;å’Œå¥½æœ‹å‹ä»¬ä¸€èµ·èšé¤ç‹‚åƒç‹‚åƒçš„ä¸¤å¤©ï¼Œä»¿ä½›å›åˆ°äº†ä¸¤å¹´å‰ä¸‹å›´ç”²çš„æ—¶å€™ï¼Œå¥½æ”¾æ¾ï½[æ¯”è€¶]å˜¿å˜¿å˜¿ï¼Œæˆ‘çˆ±å±±è¥¿é˜Ÿï¼...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-osrbt22yq/">
    
    
    
    
    
      
    
    ä¸æ„§æ˜¯æˆ‘ä»¬å±±è¥¿é˜Ÿåå®¿<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æ£‹æ‰‹æˆ˜é¹°<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@æ£‹æ‰‹æˆ˜é¹°<!-- raw HTML omitted -->:â€‚å’Œå¥½æœ‹å‹ä»¬ä¸€èµ·èšé¤ç‹‚åƒç‹‚åƒçš„ä¸¤å¤©ï¼Œä»¿ä½›å›åˆ°äº†ä¸¤å¹´å‰ä¸‹å›´ç”²çš„æ—¶å€™ï¼Œå¥½æ”¾æ¾ï½<!-- raw HTML omitted -->&lt;img alt=&quot;[æ¯”è€¶]&quot; src=&ldquo;<a href="https://face.t.sinaj">https://face.t.sinaj</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OsTwKlZpQ">å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šä¸€åŠ›è¾½ä¸‹å‡ºâ€œè¶³ä»¥è½½å…¥å†å²çš„å¦™æ‰‹â€ï¼Œè·ç¦»ä¸–ç•Œå† å†›è¿˜éœ€ä¸€èƒœã€‹ #å›´æ£‹# å›´æ£‹ ä¸€åŠ›è¾½ä¸‹å‡ºâ€œè¶³ä»¥è½½å…¥å†å²çš„å¦™æ‰‹â€ï¼Œè·ç¦»ä¸–ç•Œå† å†›è¿˜éœ€ä¸€èƒœ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-ostwklzpq/">
    
    
    
    
    
      
    
    å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šä¸€åŠ›è¾½ä¸‹å‡ºâ€œè¶³ä»¥è½½å…¥å†å²çš„å¦™æ‰‹â€ï¼Œè·ç¦»ä¸–ç•Œå† å†›è¿˜éœ€ä¸€èƒœã€‹ <!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted -->&lt;/ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/OsU90gTQx">æ£‹æ‰‹æˆ˜é¹°æˆ‘ä¸å¤ªæ‡‚ï¼Œè¥¿æ¸¸è®°è¦ç¿»æ‹äº†ï¼Ÿ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-osu90gtqx/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æ£‹æ‰‹æˆ˜é¹°<!-- raw HTML omitted --><!-- raw HTML omitted -->æˆ‘ä¸å¤ªæ‡‚ï¼Œè¥¿æ¸¸è®°è¦ç¿»æ‹äº†ï¼Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OsOOilTMz">ä¹…ä¿å²ç»ªé‡Œvia.ç·’è¡Œè¨˜fb [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-osooiltmz/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.ç·’è¡Œè¨˜fb <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OsQ30eb2D">ä¹…ä¿å²ç»ªé‡Œ[è€¶][äº²äº²] - è½¬å‘ @é•·äº­æ¢…:&amp;ensp;æ¢…æ³½ç¾æ³¢#æ¢…æ³½ç¾æ³¢# 2024.08.12 æ‰‹æœºmailã€Œæ¢…ç»ªã€&lt;å›¾&gt;æ˜¯æ¢…ç»ªå“¦â˜ºï¸â˜ºï¸MVä¸€ç›´åœ¨ä¸€èµ· [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-osq30eb2d/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/OsQAIf5Lr">æŸ¯æ´#é‡ç‹äººæ°”äº‰éœ¸èµ›##èµ›æœå‘å¸ƒ# æ½œä¼æ‰§ç™½ 164æ‰‹èƒœ æˆ‘æƒ³é™é™äº†ï¼ˆå…šæ¯…é£ä¹æ®µï¼‰ã€‚æ­å–œæŸ¯æŸ¯å…ˆä¸‹ä¸€åŸï½[é¼“æŒ][é¼“æŒ][é¼“æŒ] [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-osqaif5lr/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%87%8E%E7%8B%90%E4%BA%BA%E6%B0%94%E4%BA%89%E9%9C%B8%E8%B5%9B%23&amp;amp;extparam=%23%E9%87%8E%E7%8B%90%E4%BA%BA%E6%B0%94%E4%BA%89%E9%9C%B8%E8%B5%9B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%87%8E%E7%8B%90%E4%BA%BA%E6%B0%94%E4%BA%89%E9%9C%B8%E8%B5%9B%23&amp;amp;extparam=%23%E9%87%8E%E7%8B%90%E4%BA%BA%E6%B0%94%E4%BA%89%E9%9C%B8%E8%B5%9B</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV15E421w7zv">ä¸‹æ¬¡æ‰¾å·¥ä½œï¼Œå°±å¸¦æˆ‘å¦ˆå»ï¼</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv15e421w7zv/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1i2421Z7fH">ã€å¼ æ·æ‚è°ˆã€‘ç½‘ç»œå‹’ç´¢ç²¾å‡†è¯ˆéª—ï¼Œåº”è¯¥æŒ‰ç…§æŠ¢åŠ«å®šæ€§</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1i2421z7fh/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1qE421w7DP">ã€å¼ æ·è¯´æ³•ã€‘æ·±åº¦åè…ï¼Œä¸¥æŸ¥å¹²éƒ¨å…¼èŒåˆ©ç›Šè¾“é€</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1qe421w7dp/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1Tw4m1k7pi">ã€å¼ æ·è´¢ç»ã€‘å€Ÿè´·æ¬ºè¯ˆçš„æ™®éæ€§ä¸åˆ‘æ³•ç¼ºä½</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1tw4m1k7pi/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1V1421t7NF">è¿™å°±æ˜¯ä¸­å›½Â·é¢„å‘Šï¼šç¾å›½å†›äº‹éœ¸æƒæ­£è¿…é€Ÿä¸§å¤±ï½œæ±ªæ¶›</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1v1421t7nf/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1yi42167wx">é™ˆç¿”å…­ç‚¹åŠï¼šé‚£äº›å¹´æˆ‘ä»¬èƒŒè¿‡çš„é”…...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-08-18</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1yi42167wx/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

